Hosted on MSN2mon
Soligenix begins enrolling subjects in cutaneous T-cell lymphoma treatment trial
US-based biotechnology company Soligenix has begun enrolling subjects in its double-blind, multi-centre Phase III trial of HyBryte (synthetic hypericin), a first-in-class photodynamic therapy for ...
Yahoo Finance2d
Soligenix, Inc. (SNGX)
The confirmatory Phase 3 study (Fluorescent Light Activated Synthetic Hypericin 2, FLASH2), builds on the On Monday, Soligenix, Inc. (NASDAQ:SNGX) said it has opened patient enrollment for its ...
Medscape1mon
St. John's Wort: A Mini-Review of its Pharmacokinetics and Anti-Depressant Effects
Hypericin and hyperforin have been found to inhibit the uptake of serotonin, dopamine and norepinephrine into synaptosomes. Chronic treatment of rats with St. John's wort resulted in an up ...
The Victoria Advocate1mon
HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
The clinical study RW-HPN-MF-01, "Assessment of Treatment with Visible Light Activated Synthetic Hypericin Ointment in Mycosis Fungoides Patients" is designed as an open-label, multicenter ...